Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Daunorubicin × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 49 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Burkitt Lymphoma 9 Myelodysplastic Syndromes 7 Leukemia 7 Myeloproliferative Disorders 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Biphenotypic, Acute 4 Sarcoma, Myeloid 2 Neoplasm, Residual 2 Leukemia, Monocytic, Acute 2 Down Syndrome 2 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Philadelphia Chromosome 1 Mucositis 1 Lymphoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Basophilic, Acute 1 Hematologic Neoplasms 1 Acute Myeloid Leukemia With KMT2A Rearrangement 1

Interventions

Cyclophosphamide 58 Rituximab 47 fludarabine 38 fludarabine phosphate 25 obinutuzumab 17 venetoclax 16 Lenalidomide 16 ibrutinib 15 Etoposide 14 Prednisone 13 pirtobrutinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 11 Melphalan 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Specimen Handling 10 Filgrastim 10 Doxorubicin 10 Biopsy 10 Vincristine 9 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 pembrolizumab 8 Stem Cell Transplantation 8 Peripheral Blood Stem Cell Transplantation 8 Nivolumab 8 Gemcitabine 8 Cytarabine 8 tocilizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡